Sun Pharmaceutical Industries Share Price

ABOUT Sun Pharmaceutical Industries

• Industry Biotechnology & Drugs
• ISIN INE044A01036
• BSE Code 524715
• NSE Code SUNPHARMA

Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company with a presence in specialty, generics and consumer healthcare products. The Company's global specialty portfolio spans products in dermatology, ophthalmology, and onco-dermatologym, among others. The Company manufactures and markets a large basket of pharmaceutical formulations across chronic and acute therapies, including generic, branded generics, specialty and complex products, over-the-counter (OTC), antiretrovirals (ARV), Active Pharmaceutical Ingredients (API), and intermediates. Its portfolio spans multiple dosage forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids. Its marketed specialty portfolio includes Ilumya/ Ilumetri, Winlevi, Levulan Kerastick + BLU-U, Absorica LD, Odomzo, Cequa, Bromsite, Xelpros, and others. Its portfolio also includes UNLOXCYTTM, an anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma.

MANAGEMENT

• Dilip Shanghvi Chairman, Managing Director, Executive Director
• C. S. Muralidharan Chief Financial Officer
• Jayashree Satagopan Chief Financial Officer
• Aalok Shanghvi Whole-time Director, Executive Vice-President, Emerging Markets, Global generic R&D, Global BD (Generics Segment) & API
• Anoop Deshpande Compliance Officer, Company Secretary
• Kirti Ganorkar Managing Director
• Vidhi Shanghvi Whole-Time Director